Dual-level eco-efficiency analysis in sustainable management: An empirical study on textile manufacturers and supply chains in China

2022 ◽  
Vol 304 ◽  
pp. 114227
Author(s):  
Xinhui Ruan ◽  
Ning Ding ◽  
Jianxin Yang
2021 ◽  
Vol 9 (2) ◽  
pp. 343-350 ◽  
Author(s):  
Tetyana Skrypko ◽  
Nazariy Popadynets ◽  
Tetiana Yakhno ◽  
Roman Shulla ◽  
Tetiana Vlasenko ◽  
...  

The paper shows the results of an empirical study on the optimization of polymer waste supply chains based on the circular economy in Ukraine. The research shows that the main links in the activity should be harmonized for quality and quick optimization of polymer waste supply chains, including the processes of collecting, sorting, treatment, processing, and recycling of resources for maintaining the quality by total cost reduction. The research argues that the circular economy that stipulates the easy processing, recycling, disassembling, and restoring of products replaced the traditional linear model “take, produce, and throw out” that has dominated the economy by now. The study shows that the transformation of supply chains in production ecosystems forms competitive advantages at the enterprises that allow them to be more productive through efficient use of resources.


2019 ◽  
Vol 11 (18) ◽  
pp. 4881 ◽  
Author(s):  
Changhyeon Song ◽  
Kwangsoo Shin

Given high business risks and interdependency with various organizations in biopharmaceutical industry, business model has become a key element for firms that aim to be more sustainable and profitable. Despite its growing importance, research on the business model design in biopharmaceutical industry is limited. In particular, there is a lack of research dealing with business models or strategies for latecomers. In the face of drastic changes such as market expansion and patent expiration, there has been growing interest in latecomer’s business model in the biopharmaceutical industry. This study identifies different types of business model designs using hierarchical clustering. Based on an empirical study of 313 biopharmaceutical firms in Korea, we find three types of business models: business diversified research firm, non-diversified research firm, and mature firm. We then compare the general characteristics and performances of each cluster. The findings indicate that business diversification of biopharmaceutical firms is beneficial in terms of profit. This implies that the biopharmaceutical firms in latecomer countries such as Korea are recommended to consider business diversification for sustainable management.


Author(s):  
Mehmood Khan ◽  
Mian M. Ajmal ◽  
Angappa Gunasekaran ◽  
Abdulla H. AlMarzouqi ◽  
Bader Khamis AlNuaimi

2019 ◽  
Vol 66 (1) ◽  
pp. 8-19 ◽  
Author(s):  
Rameshwar Dubey ◽  
Angappa Gunasekaran ◽  
Stephen J. Childe ◽  
Thanos Papadopoulos ◽  
Constantin Blome ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document